07 Jan 2022 --- This week in nutrition news, Evolva has secured up to US$13 million in financing from Nice & Green, while the debate over the use of N-acetyl-L-cysteine (NAC) in supplements between the Council for Responsible Nutrition and the US Food and Drug Administration (FDA) showed no signs of ending. Meanwhile, the use of psilocybin has been found to have no detrimental effects in healthy people, paving the way for its use in treating mental health issues.
